Sun Pharma ropes in Richard Ascroft as North America CEO
Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…
Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC
New Delhi: In a regulatory relief to the company, the Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation (CDSCO) has recommended…
Sun Pharma appoints Kirti Ganorkar as the Managing Director
Sun Pharmaceutical Industries Limited has announced appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting…
Sun Pharma to invest $25 million in Pharmazz Inc; raises stake to 22.7%
Sun Pharmaceutical Industries Ltd on Friday announced it will invest up to $25 million in US-based Pharmazz Inc, increasing its total stake in the biopharmaceutical company to 22.7 per cent.…
Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.
Divis Laboratories has entered into a long term manufacturing and supply agreement with a global pharma company. Under this agreement, the Company will be manufacturing and supplying advanced intermediates as…
Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment
Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades. The Mumbai-based drug major, in a statement, said it has…
India’s Pharma Industry Raises Concerns Of Shortage & Costlier Medicine For Americans Over Proposed US Tariffs
The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential…
US Tariffs on pharma: What are the potential impact on Indian drugmakers
US tariffs on pharmaceutical imports by the US President Donald Trump have sparked concerns within India’s pharma sector, a global leader in affordable generic drug supplies. In an exclusive interaction…
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%
Share of pharma companies saw red on February 14 as caution over the possibility of US tariffs hitting the sector spread across the Street. This came after US President Donald…
Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer
Sun Pharmaceutical Industries has appointed Aalok Shanghvi as its Chief Operating Officer (COO). The company announced the designation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.…
